This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Luxembourg Institute of Health (Lih), Universite De Reims Champagne Ardenne (u.r.c.a.). Active years: 2022.
Company Filing History:
1 out of 3 
1 out of 2 Years Active: 2022
Title: Carole Devaux: Innovator in Targeted Therapies
Introduction
Carole Devaux is a prominent inventor based in Zoufftgen, France. She has made significant contributions to the field of targeted therapies through her innovative work in protein complexes. Her research focuses on developing multifunctional heteromultimeric constructs that can enhance therapeutic efficacy.
Latest Patents
Carole Devaux holds one patent titled "Multifunctional heteromultimeric constructs." This invention is situated in the field of multimers used for targeted therapies. It relates to methods for preparing multifunctional heteromultimeric protein complexes with a defined ratio of functional components. The invention aims to direct complement-dependent cytolysis and includes a tracking component among its functional elements.
Career Highlights
Throughout her career, Carole has worked with esteemed institutions such as the Luxembourg Institute of Health and Université de Reims Champagne Ardenne. Her work has been pivotal in advancing the understanding and application of targeted therapies in medical science.
Collaborations
Carole has collaborated with notable professionals in her field, including Xavier Dervillez and Jacques H. M. Cohen. These collaborations have further enriched her research and contributed to the development of her innovative constructs.
Conclusion
Carole Devaux is a trailblazer in the realm of targeted therapies, with her patent showcasing her commitment to advancing medical science. Her work continues to inspire future innovations in the field.